Fig. 3From: Investigation and modulation of interleukin-6 following subarachnoid hemorrhage: targeting inflammatory activation for cerebral vasospasmIL-6 was significantly increased in CSF of SAH patients compared to control (p < 0.01) (A). No significant change was observed between groups for peripheral serum samples (p = 0.55) (B). A selective small molecule inhibitor to target the downstream cascade of IL-6 via p-STAT3 inhibition was synthesized (C)Back to article page